During the past decade, ForCare Clinical Research, Inc. conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 5 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "ForCare Clinical Research, Inc." are "Dermatitis, Atopic" (3 trials), "Hidradenitis Suppurativa" (3 trials), "Plaque Psoriasis" (3 trials), "Atopic Dermatitis" (2 trials) and "Acne Inversa" (1 trials). Many other conditions were trialed in "ForCare Clinical Research, Inc." in a lesser frequency.

Most popular intervention types in "ForCare Clinical Research, Inc." are "Drug" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Bermekimab" (2 trials), "Guselkumab" (2 trials), "JNJ-77242113" (2 trials) and "Vehicle" (2 trials). Other intervention names were less common.

The vast majority of trials in "ForCare Clinical Research, Inc." are 16 trials for "All" genders.

Currently, there are NaN active trials in "ForCare Clinical Research, Inc.". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in ForCare Clinical Research, Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in ForCare Clinical Research, Inc., 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".